retatrutide ly3437943 triple agonist glp-1 gip glucagon for Weight Loss: What It Is, How It Works & Side Effects retatrutide triple agonist glp-1 gip

However, integration of results from recent GLP-1 RA and older weight loss drug trials suggest a good correlation between weight loss and a decrease in BP (R 2 = 0.91 for SBP), a result mainly driven by GLP-1 RAs (Fig

Here is a reference framework based on the available data and documented outcomes

Nausea remains but feels slightly less constant

Monitoring vital signs, fluid balance, and electrolyte levels helps identify dehydration, electrolyte imbalances, and prevents complications such as fluid overload or cardiac dysrhythmias

Peptides 100 , 150157 (2018)

Retatrutide is a once-weekly injectable medication currently in development for weight management and metabolic disorders